Paul Bresge has a wealth of experience in corporate management mainly in the field of regenerative medicine in the United States. He has a proven track record of success especially in launching and running businesses specializing in research and development of treatment for retinitis pigmentosa that can cause blindness. He became an outside director of Healios in 2022.